DK2467173T3 - Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf - Google Patents

Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf Download PDF

Info

Publication number
DK2467173T3
DK2467173T3 DK10747385.2T DK10747385T DK2467173T3 DK 2467173 T3 DK2467173 T3 DK 2467173T3 DK 10747385 T DK10747385 T DK 10747385T DK 2467173 T3 DK2467173 T3 DK 2467173T3
Authority
DK
Denmark
Prior art keywords
procedures
wools
Prior art date
Application number
DK10747385.2T
Other languages
English (en)
Inventor
Nathan Stasko
Susanne Bauman
Pranav R Joshi
Original Assignee
Novan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novan Inc filed Critical Novan Inc
Application granted granted Critical
Publication of DK2467173T3 publication Critical patent/DK2467173T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114Nitric oxide, i.e. NO
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
DK10747385.2T 2009-08-21 2010-08-20 Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf DK2467173T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23592709P 2009-08-21 2009-08-21
US23594809P 2009-08-21 2009-08-21
PCT/US2010/046209 WO2011022680A2 (en) 2009-08-21 2010-08-20 Wound dressings, methods of using the same and methods of forming the same

Publications (1)

Publication Number Publication Date
DK2467173T3 true DK2467173T3 (da) 2019-07-29

Family

ID=43446983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10747385.2T DK2467173T3 (da) 2009-08-21 2010-08-20 Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf

Country Status (7)

Country Link
US (2) US9919072B2 (da)
EP (1) EP2467173B8 (da)
CN (1) CN102695528B (da)
BR (1) BR112012003804B1 (da)
CA (1) CA2771389C (da)
DK (1) DK2467173T3 (da)
WO (1) WO2011022680A2 (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871433B1 (en) 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US9173674B2 (en) 2010-08-06 2015-11-03 MoMelan Technologies, Inc. Devices for harvesting a skin graft
US9610093B2 (en) 2010-08-06 2017-04-04 Kci Licensing, Inc. Microblister skin grafting
US8978234B2 (en) 2011-12-07 2015-03-17 MoMelan Technologies, Inc. Methods of manufacturing devices for generating skin grafts
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
PT2550977T (pt) * 2011-07-27 2017-08-08 Genewel Co Ltd Penso em espuma de poliuretano com excelentes propriedades adesivas e método de fabrico do mesmo
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
WO2013063354A1 (en) 2011-10-27 2013-05-02 Novan, Inc. Nitric oxide releasing bath compositions and methods of using the same
CN107522880B (zh) * 2012-01-25 2020-07-24 阿克伦大学 水凝胶及其制备方法
ES2861439T3 (es) * 2012-03-14 2021-10-06 Novan Inc Composiciones farmacéuticas que liberan óxido nítrico
CN103690490B (zh) 2012-08-23 2017-11-17 尼奥克斯(文莱)控股有限公司 基于微囊化化学试剂延时产生一氧化氮的系统和方法
CA2899477C (en) * 2013-02-07 2019-09-17 The Regents Of The University Of Michigan Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
CN105636532B (zh) * 2013-03-14 2019-06-21 凯希特许有限公司 用于采集皮肤移植片的吸收性基底
WO2014169281A1 (en) * 2013-04-12 2014-10-16 Colorado State University Research Foundation Surface treatments for vascular stents and methods thereof
DE102013107464A1 (de) * 2013-07-15 2015-01-15 Wilhelm Fleischmann Wundauflage
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
WO2015057964A2 (en) * 2013-10-16 2015-04-23 The Board Of Regents Of The University Of Texas System Modulation of mrtf-a activity in pathologic fibrosis and wound healing
US20150157657A1 (en) * 2013-10-18 2015-06-11 Bovicor Pharmatech Inc. Preparation and delivery of sustained nitric oxide releasing solutions
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US10626290B2 (en) * 2013-12-16 2020-04-21 Ppg Industries Ohio, Inc. Method of extending pot life of coating compositions
EP3243453B1 (en) 2013-12-31 2019-10-09 KCI Licensing, Inc. Skin graft harvesting device
US10463392B2 (en) 2013-12-31 2019-11-05 Kci Licensing, Inc. Fluid-assisted skin graft harvesting
EP3166593B1 (en) 2014-07-11 2020-05-20 Novan, Inc. Topical antiviral compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
EP3177262A4 (en) 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
FR3025429B1 (fr) * 2014-09-08 2018-02-02 Urgo Recherche Innovation Et Developpement Fibre electronegative pour son utilisation dans la cicatrisation des plaies
EP3804774A1 (en) 2015-04-09 2021-04-14 3M Innovative Properties Co. System for harvesting skin grafts
WO2016201237A1 (en) * 2015-06-11 2016-12-15 The Regents Of The University Of Michigan Nitric oxide releasing plga microspheres for biomedical applications
WO2017019614A1 (en) 2015-07-28 2017-02-02 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
EP3370630B1 (en) 2015-11-03 2021-06-16 3M Innovative Properties Company Device for creating an epidermal graft sheet
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
EP3570927A4 (en) * 2017-01-21 2020-12-23 Biocrede Inc. MEDICAL PRODUCTS AND METHODS FOR THE CONTROLLED RELEASE OF NITROGEN OXIDE
WO2018236803A1 (en) 2017-06-19 2018-12-27 Novan, Inc. Topical compositions and methods of using the same
GB201713511D0 (en) 2017-08-23 2017-10-04 Scapa Uk Ltd Wound dressing
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーOnquality Pharmaceuticals China Ltd. Egfr阻害に関連する疾患を予防又は治療する方法
WO2019169221A1 (en) 2018-03-01 2019-09-06 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
KR102831159B1 (ko) 2018-04-16 2025-07-07 온퀄리티 파마슈티컬스 차이나 리미티드 암 치료의 부작용을 예방하거나 치료하기 위한 방법
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108755137A (zh) * 2018-06-05 2018-11-06 北京服装学院 一种抗凝血的纺织基人造血管材料及其制备方法
WO2020018488A1 (en) * 2018-07-16 2020-01-23 University Of Georgia Research Foundation, Inc. Robust nitric oxide-releasing polymers and articles and methods of making and uses thereof
CN109124096B (zh) * 2018-08-23 2021-08-06 广州百隆威尔精密五金制品有限公司 一种升降橱柜
EP3930771A4 (en) * 2019-02-26 2022-11-02 University of Georgia Research Foundation, Inc. ANTIBACTERIAL WOUND TREATMENT WITH COAGULATORY PROPERTIES
BR112021022291A2 (pt) 2019-05-08 2021-12-28 Saint Gobain Performance Plastics Corp Composições poliméricas hidrofílicas
CN110639052B (zh) * 2019-09-30 2021-06-29 新乡医学院 一种促进创面愈合的复合凝胶体系及其制备方法和应用
CN110522766B (zh) * 2019-09-30 2021-09-28 新乡医学院 一种负载肿瘤外泌体的凝胶体系及其制备方法和应用
CN110563974B (zh) * 2019-09-30 2021-09-28 新乡医学院 一种活性氧响应的自崩解水凝胶及其制备方法和应用
GB2588748A (en) * 2019-10-07 2021-05-12 Insense Ltd Composition for delivering nitric oxide to skin
EP4041326A4 (en) * 2019-10-10 2023-11-01 Keneric Healthcare, LLC FOAM-BASED SURFACTANT
TR201917675A2 (tr) * 2019-11-13 2021-05-21 Ulusal Bor Arastirma Enstituesue Bi̇r yara bakim ürünü
CN111617304B (zh) * 2020-06-15 2022-01-14 江苏阳生生物股份有限公司 一种高吸湿创口敷料及其制备方法
US12447051B2 (en) 2020-08-24 2025-10-21 University Of Utah Research Foundation Multi-functional analgesic-releasing wound dressing
CN112250901B (zh) * 2020-11-06 2022-04-01 江苏海洋大学 一种多功能互穿网络聚合物乳液在聚氨酯软泡塑料改性中的应用
WO2022162581A1 (en) * 2021-02-01 2022-08-04 3M Innovative Properties Company Reinforced fiber web and wound dressing material including the same
CN113679874B (zh) * 2021-09-03 2022-07-22 明基材料有限公司 多段释放敷料
US20250129265A1 (en) * 2021-09-20 2025-04-24 University Of Georgia Research Foundation, Inc. Nitric oxide releasing polysiloxanes and methods for making and using the same
EP4198094A1 (de) * 2021-12-20 2023-06-21 Covestro Deutschland AG Mehrschichtaufbau auf metallischen untergründen basierend auf polyaspartatbeschichtungen
US12185929B2 (en) 2023-03-17 2025-01-07 DRS Vascular, Inc. Suture retention device
CN116688209B (zh) * 2023-06-06 2025-06-24 江南大学 一种医用敷料、制备方法及应用
TR2023017919A2 (tr) * 2023-12-21 2024-04-22 Acibadem Mehmet Ali̇ Aydinlar Üni̇versi̇tesi̇ Bi̇r yara örtüsü
CN117599260A (zh) * 2024-01-23 2024-02-27 四川大学 一种具有抗炎功能的医用聚氨酯泡沫及其制备和应用
EP4640246A1 (en) 2024-04-25 2025-10-29 Viscofan España, S.L.U. A topical dressing comprising a polyamide/pvp film

Family Cites Families (467)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173691A (en) 1978-02-21 1979-11-06 M&T Chemicals Inc. Catalyst composition for flexible polyurethane foams
US4182827A (en) * 1978-08-31 1980-01-08 Union Carbide Corporation Polyurethane hydrogels having enhanced wetting rates
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4631337A (en) 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4600001A (en) * 1984-08-15 1986-07-15 The Kendall Company Combined wound dressing and delivery means composite
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4550126A (en) * 1985-01-25 1985-10-29 Hydromer, Inc. Hydrophilic, flexible, open cell polyurethane-poly(N-vinyl lactam) interpolymer foam and dental and biomedical products fabricated therefrom
US4871779A (en) 1985-12-23 1989-10-03 The Dow Chemical Company Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities
US4694064A (en) 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer
US4713975A (en) 1986-05-30 1987-12-22 The Dow Chemical Company Dense star polymers for calibrating/characterizing sub-micron apertures
US4857599A (en) 1988-02-08 1989-08-15 The Dow Chemical Company Modified dense star polymers
US5045322A (en) 1988-05-09 1991-09-03 Dow Corning Corporation Antimicrobial superabsorbent sanitary napkin
US5035892A (en) 1988-05-09 1991-07-30 Dow Corning Corporation Antimicrobial superabsorbent compositions and methods
US4990338A (en) 1988-05-09 1991-02-05 Dow Corning Corporation Antimicrobial superabsorbent compositions and methods
US5061487A (en) 1988-05-09 1991-10-29 Dow Corning Corporation Antimicrobial superabsorbent compositions and methods
US4985023A (en) 1988-05-09 1991-01-15 Dow Corning Corporation Antimicrobial superabsorbent articles
US5079004A (en) 1990-08-06 1992-01-07 Dow Corning Corporation Antimicrobial superabsorbent compositions and method
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
US5380758A (en) 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US6291424B1 (en) 1991-11-14 2001-09-18 Brigham And Women's Hospital Nitrosated and nitrosylated heme proteins
AU3071592A (en) 1991-11-14 1993-06-15 Brigham And Women's Hospital Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
US5194325A (en) 1992-02-25 1993-03-16 Renosol Corporation Molded polyurethane foam system utilizing HFC blowing agents
SE9200564L (sv) 1992-02-26 1993-03-15 Perstorp Ab Dendritisk makromolekyl av polyestertyp, foerfarande foer framstaellning daerav samt anvaendning daerav
US5814666A (en) 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5650447A (en) 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5525357A (en) 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5691423A (en) 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5632981A (en) 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5861168A (en) 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5852058A (en) 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5428070A (en) 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
EP1393723A3 (en) 1993-09-17 2004-10-20 The Brigham And Women's Hospital, Inc. Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
US6255277B1 (en) 1993-09-17 2001-07-03 Brigham And Women's Hospital Localized use of nitric oxide-adducts to prevent internal tissue damage
US6087479A (en) 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
CA2173738A1 (en) 1993-10-08 1995-04-20 James B. Mitchell Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
US5840759A (en) 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
JPH09508097A (ja) 1993-11-02 1997-08-19 アメリカ合衆国 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用
US5786332A (en) 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5726156A (en) 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5599984A (en) 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US6008255A (en) 1994-01-21 1999-12-28 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
DK0746327T3 (da) 1994-02-21 2004-05-10 Univ Aberdeen Forsuret nitrit som antimikrobielt middel
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US5504117A (en) 1994-05-27 1996-04-02 Neptune Pharmaceutical Corporation Pharmacologic preparation for the treatment of anal disorders
JP3211892B2 (ja) 1994-05-27 2001-09-25 セイジィ ファーマスーティカルス インコーポレーテッド 肛門疾患を治療する窒素酸化物供与体及び方法
US6190704B1 (en) 1994-09-23 2001-02-20 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
US6747062B2 (en) 1994-09-26 2004-06-08 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
US5519020A (en) 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
US5629322A (en) 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase
US5700830A (en) 1994-11-22 1997-12-23 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents for reducing metastasis risk
US5810010A (en) 1995-01-03 1998-09-22 Anbar; Michael Detection of cancerous lesions by their effect on the periodic modulation of perfusion in the surrounding tissues
US5999843A (en) 1995-01-03 1999-12-07 Omnicorder Technologies, Inc. Detection of cancerous lesions by their effect on the spatial homogeneity of skin temperature
US6035225A (en) 1995-01-03 2000-03-07 Omnicorder Technologies Detection of cancerous lesions by measuring nitric oxide concentrations in tissue
US5961466A (en) 1995-01-03 1999-10-05 Omnicorder Technologies, Inc. Method of detection of cancerous lesions by their effect on the spatial distribution of modulation of temperature and homogeneity of tissue
ATE252894T1 (de) 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
US5665077A (en) 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5623981A (en) 1995-08-17 1997-04-29 Service Station Products Company Safety barrier for rim holding tire changers
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
DE69637676D1 (de) 1995-11-09 2008-10-23 Univ R Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US5821261A (en) 1995-12-08 1998-10-13 Merck & Co., Inc. Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US20050065161A1 (en) 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US5994294A (en) 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US20020143007A1 (en) 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US5932538A (en) 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US20020061879A1 (en) 1996-02-02 2002-05-23 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
IT1282686B1 (it) 1996-02-26 1998-03-31 Nicox Sa Composti in grado di ridurre la tossicita' da farmaci
EP0907747A1 (en) 1996-03-15 1999-04-14 Yale University Methods and means of detecting nitric oxide synthase
US5968001A (en) 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
US6143037A (en) 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US5789451A (en) 1996-07-29 1998-08-04 The Dow Chemcial Company Alkanolamine/carbon dioxide adduct and polyurethane foam therewith
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5770645A (en) 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US20030093143A1 (en) 1999-03-01 2003-05-15 Yiju Zhao Medical device having surface depressions containing nitric oxide releasing compound
AU3986097A (en) 1996-08-27 1998-03-19 University Of Akron, The Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
US5797887A (en) 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
CA2266908C (en) 1996-09-27 2010-07-20 Joseph E. Saavedra O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
GB9622997D0 (en) 1996-11-05 1997-01-08 Univ St Andrews Nitric oxide donor drugs
US5958427A (en) 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
US6372796B1 (en) 1996-11-13 2002-04-16 Cold Spring Harbor Laboratory Therapeutic uses for nitric oxide inhibitors
US5891472A (en) 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
EP0957901B1 (en) 1996-12-31 2009-11-18 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
CA2277076C (en) 1997-01-17 2006-04-04 Cascade Engineering, Inc. Mat with integrally molded door
AU6139798A (en) 1997-02-04 1998-08-25 General Hospital Corporation, The A novel method for treating epidermal or dermal conditions
US6034752A (en) 1997-03-22 2000-03-07 Kent Displays Incorporated Display device reflecting visible and infrared radiation
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
US5968528A (en) 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
US6171232B1 (en) 1997-06-26 2001-01-09 Cordis Corporation Method for targeting in vivo nitric oxide release
JP4856295B2 (ja) 1997-07-03 2012-01-18 アメリカ合衆国政府 新規な一酸化窒素放出アミジン誘導ジアゼニウムジオレート及びその組成物
US6796966B2 (en) 1997-10-15 2004-09-28 Jeffrey E. Thomas Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
US6358536B1 (en) 1997-10-15 2002-03-19 Thomas Jefferson University Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
US5994444A (en) 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US20020013304A1 (en) 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
CA2219867A1 (en) 1997-10-31 1999-04-30 Jiangping Wu The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
US6180082B1 (en) 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
AU1770299A (en) 1997-12-23 1999-07-19 Nycomed Imaging As Nitric oxide releasing chelating agents and their therapeutic use
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
IT1298338B1 (it) 1998-03-05 1999-12-20 Nicox Sa Composizioni farmaceutiche per l'ulcera
US6560478B1 (en) 1998-03-16 2003-05-06 The Research Foundation Of City University Of New York Method and system for examining biological materials using low power CW excitation Raman spectroscopy
US6151522A (en) 1998-03-16 2000-11-21 The Research Foundation Of Cuny Method and system for examining biological materials using low power CW excitation raman spectroscopy
US5962520A (en) 1998-04-02 1999-10-05 The University Of Akron Hydrolytically unstable, biocompatible polymer
US6103266A (en) 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US6103275A (en) 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
US20020068365A1 (en) 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
US20060240070A1 (en) * 1998-09-24 2006-10-26 Cromack Keith R Delivery of highly lipophilic agents via medical devices
US6299980B1 (en) 1998-09-29 2001-10-09 Medtronic Ave, Inc. One step lubricious coating
US20040043068A1 (en) 1998-09-29 2004-03-04 Eugene Tedeschi Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6379691B1 (en) 1998-09-29 2002-04-30 Medtronic/Ave, Inc. Uses for medical devices having a lubricious, nitric oxide-releasing coating
DE19852681A1 (de) * 1998-11-16 2000-05-18 Basf Ag Carbamatlösungen
US20070275100A1 (en) 1998-11-23 2007-11-29 Miller Christopher C Use of gaseous nitric oxide as an anti-cancer agent
CA2254645A1 (en) 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US20070086954A1 (en) 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6238683B1 (en) 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US20050142218A1 (en) 2000-03-09 2005-06-30 Queen Mary & Westfield College Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
US6312663B1 (en) 1999-03-19 2001-11-06 Joseph V. Boykin, Jr. Prediction of diabetes impaired wound healing by urinary nitrate assay
US6562785B1 (en) 1999-03-23 2003-05-13 Howard M. Shapiro Method for overcoming bacterial antibiotic resistance
EP1176995A1 (en) * 1999-05-07 2002-02-06 Salviac Limited A tissue engineering scaffold
US7135498B1 (en) 1999-06-14 2006-11-14 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
US7655423B2 (en) 1999-06-14 2010-02-02 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
EP1233670B1 (en) 1999-06-14 2008-09-17 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
US20010012851A1 (en) 1999-07-29 2001-08-09 Kristin M. Lundy Nitric oxide releasing oxindole prodrugs for anagesic, anti-inflammatory and disease-modifying use
US20020049157A1 (en) 1999-08-25 2002-04-25 Jiangping Wu Use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
US7279176B1 (en) 1999-09-02 2007-10-09 Rice University Nitric oxide-producing hydrogel materials
US7052711B2 (en) 1999-09-02 2006-05-30 Rice University Nitric oxide-producing hydrogel materials
WO2001015738A2 (en) 1999-09-02 2001-03-08 Rice University Nitric oxide-producing hydrogel materials
CA2384531A1 (en) * 1999-09-09 2001-03-15 Creavis Gesellschaft Fur Technologie Und Innovation Mbh Antimicrobial additives
US6737447B1 (en) 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US20030134779A1 (en) 1999-12-20 2003-07-17 Diarra Moussa S. Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
US6492405B2 (en) 1999-12-30 2002-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nitric oxide donors and pharmaceutical compositions containing them
WO2001053537A2 (en) 2000-01-24 2001-07-26 Dzgenes, Llc Nitric oxide synthase gene diagnostic polymorphisms
US6758214B2 (en) 2000-01-28 2004-07-06 Cyterra Corporation Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
US6699846B2 (en) 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
EP1267837A4 (en) 2000-03-20 2006-05-03 Novovascular Inc MATRICES COMPRISING NITRIC OXIDE DONORS AND REDUCING AGENTS AND THEIR USE
US20010038832A1 (en) 2000-04-11 2001-11-08 Benjamin Bonavida Nitric oxide and analogues thereof effectuate sensitization of neoplasm and immunologically undesired tissues to cytotoxicity
US7678391B2 (en) 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
ES2232613T3 (es) 2000-04-26 2005-06-01 Cellegy Pharmaceuticals, Inc Formulaciones y metodos de utilizacion de agentes mimeticos del oxido nitrico contra un fenotipo celular maligno.
US20050142217A1 (en) 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20010053772A1 (en) 2000-04-28 2001-12-20 Benjamin Bonavida Aza analogues of alkyl lysophospholipids exert immunomodulatory effects
US6270779B1 (en) 2000-05-10 2001-08-07 United States Of America Nitric oxide-releasing metallic medical devices
AU2001264729A1 (en) 2000-05-22 2001-12-03 Nitromed, Inc. Thromboxane inhibitors, compositions and methods of use related applications
US6623728B2 (en) 2000-06-30 2003-09-23 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic skin care compositions and containing gum mastic
US6475500B2 (en) 2000-07-10 2002-11-05 The Procter & Gamble Company Anhydrous cosmetic compositions
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
JP4841066B2 (ja) 2000-09-01 2011-12-21 ライスユニバーシティ 酸化窒素生成ヒドロゲル物質
GB0022084D0 (en) 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US6410622B1 (en) 2000-09-11 2002-06-25 Gregory W. Endres Method of preventing fouling organisms in marine environments and polymer-bound nitric oxide/nitric oxide-releasing compositions usable therefor
DE60141703D1 (de) 2000-10-16 2010-05-12 Univ Duke Therapeutische anwendung von zerstäubtem s-nitrosoglutathion bei zystischer fibrose
WO2002032413A2 (en) 2000-10-17 2002-04-25 Board Of Regents, The University Of Texas System A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
US6359182B1 (en) 2000-10-26 2002-03-19 Duke University C-nitroso compounds and use thereof
US7049308B2 (en) 2000-10-26 2006-05-23 Duke University C-nitroso compounds and use thereof
KR100383149B1 (ko) 2000-12-12 2003-05-12 한국생명공학연구원 디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도
DE10063937A1 (de) 2000-12-20 2002-07-18 Bayer Ag Verfahren zur Herstellung von Trimethylolverbindungen und Ameisensäure
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US7329412B2 (en) 2000-12-22 2008-02-12 The Trustees Of Columbia University In The City Of New York Antimicrobial medical devices containing chlorhexidine free base and salt
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US20040009238A1 (en) 2002-07-09 2004-01-15 Chris Miller Exogenenous nitric oxide gas (gNO) therapy in wound healing
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
JP2004516369A (ja) * 2000-12-27 2004-06-03 ワールド・プロパティーズ・インコーポレイテッド ポリウレタンフォームとその製造方法
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
CA2433803A1 (en) 2001-01-16 2002-07-25 Mark E. Meyerhoff Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US6706274B2 (en) 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
ITMI20010426A1 (it) 2001-03-01 2002-09-01 Consiglio Nazionale Ricerche Donatori di ossido di azoto basati su centri metallici
US7012098B2 (en) 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
US20020138051A1 (en) 2001-03-26 2002-09-26 Hole Douglas R. System and method for the prevention and treatment of animal wound infections using nitric oxide
EP1395241B9 (en) 2001-05-25 2005-06-15 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
ES2180446B1 (es) 2001-07-02 2004-01-16 Esteve Labor Dr Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
WO2003006427A1 (en) 2001-07-12 2003-01-23 Johns Hopkins University Compounds that release nitric oxide at controlled rates upon photolysis
GB0119011D0 (en) 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
EP1427323A4 (en) 2001-08-20 2004-09-15 Univ Virginia USE OF S-NITROSOTHIOL SIGNALING TO TREAT BREATH CONTROL DISORDERS
US6841166B1 (en) 2001-08-21 2005-01-11 The Regents Of The University Of Michigan Nitric oxide-releasing polymers incorporating diazeniumdiolated silane derivatives
US7135189B2 (en) 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
EP1429829B1 (en) 2001-09-05 2013-11-27 Geno LLC Nitric oxide generation
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
WO2003026717A1 (en) * 2001-09-26 2003-04-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Nitric oxide-releasing coated medical devices and method of preparing same
US6703046B2 (en) 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
EP1300083A1 (en) 2001-10-04 2003-04-09 Societe Des Produits Nestle S.A. Milk-based snack
GB0125222D0 (en) 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US6472390B1 (en) 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
US6627602B2 (en) 2001-11-13 2003-09-30 Duke University Preventing desensitization of receptors
US20040110691A1 (en) 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
CN1612804A (zh) * 2001-12-03 2005-05-04 C·R·巴德公司 抗微生物医用器材、抗微生物聚合物涂层及其制备方法
US7176237B2 (en) 2002-01-15 2007-02-13 The Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
US6474508B1 (en) 2002-01-24 2002-11-05 Saint-Gobain Calmar Inc. Unit dose tube and cap assembly
US20030219854A1 (en) 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
EP1490045B1 (en) 2002-03-21 2013-03-13 University of Utah Research Foundation In vivo use of glutathionone s-transferase activated nitric oxide donors
BRPI0309022A2 (pt) * 2002-04-04 2016-11-08 Univ Akron conjuntos de fibra não tecida
AU2003223491A1 (en) 2002-04-05 2003-10-27 Nitromed, Inc. Nitric oxide donors, compositions and methods of use
AU2003237128A1 (en) 2002-05-03 2003-11-17 Duke University Carbon nanotubules for storage of nitric oxide
CA2485167A1 (en) 2002-05-07 2003-11-20 The Government Of The United States Of America Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
JP2006515859A (ja) 2002-05-13 2006-06-08 トラスティーズ オブ ダートマス カレッジ 阻害剤およびその使用法
US7070798B1 (en) 2002-06-21 2006-07-04 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
CN1674942A (zh) 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶-1和血红素降解产物的药学用途
US6949530B2 (en) 2002-07-18 2005-09-27 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
WO2004009253A1 (en) 2002-07-19 2004-01-29 University Of North Carolina At Chapel Hill Surface-localized release of an anti-biofouling agent via micropatterning
EP1527045A1 (en) 2002-07-26 2005-05-04 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
US7303575B2 (en) * 2002-08-01 2007-12-04 Lumen Biomedical, Inc. Embolism protection devices
EP1545798A4 (en) 2002-08-02 2006-06-14 Us Gov Health & Human Serv NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R
US20040076582A1 (en) 2002-08-30 2004-04-22 Dimatteo Kristian Agent delivery particle
US20050080024A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20040033480A1 (en) 2002-08-15 2004-02-19 Wong Norman C.W. Use of resveratrol to regulate expression of apolipoprotein A1
US20050080021A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
US6951902B2 (en) 2002-08-16 2005-10-04 Michigan Biotechnology Institute Two dimensional polymer that generates nitric oxide
US7674482B2 (en) 2002-08-27 2010-03-09 Targeted Medical Pharma Inc. Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
US20100210745A1 (en) * 2002-09-09 2010-08-19 Reactive Surfaces, Ltd. Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
US20030039697A1 (en) 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
EP1562914A1 (en) 2002-10-22 2005-08-17 Merck Frosst Canada & Co. Nitric oxide releasing selective cyclooxygenase-2 inhibitors
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080317679A1 (en) 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
GB0224986D0 (en) * 2002-10-28 2002-12-04 Smith & Nephew Apparatus
WO2004046309A2 (en) 2002-11-18 2004-06-03 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
WO2004060283A2 (en) 2002-12-16 2004-07-22 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
WO2004064767A2 (en) 2003-01-23 2004-08-05 Kahn Nighat N Nitric oxide inducing agents
FR2850578B1 (fr) 2003-02-03 2006-07-28 Oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
CA2517490A1 (en) 2003-03-05 2004-12-02 Merck Frosst Company Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
EP1603933A2 (en) 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
SE0300971D0 (sv) 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
US20040254419A1 (en) 2003-04-08 2004-12-16 Xingwu Wang Therapeutic assembly
US20050079132A1 (en) 2003-04-08 2005-04-14 Xingwu Wang Medical device with low magnetic susceptibility
US7972137B2 (en) 2003-06-30 2011-07-05 Rosen Gerald M Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
US7256921B2 (en) 2003-07-01 2007-08-14 Transitions Optical, Inc. Polarizing, photochromic devices and methods of making the same
NZ545001A (en) 2003-07-03 2009-09-25 Univ St Andrews Zeolites for delivery of nitric oxide
DE10330960B4 (de) * 2003-07-08 2005-09-08 Stockhausen Gmbh Wirkstoffdotierte absorbierende Polymerteilchen , Zusammensetzung beinhaltend Polykondensatmatrix und absorbierendes Polymer zur Freisetzung einer Wundheilsubstanz
US7234079B2 (en) 2003-07-11 2007-06-19 Agency For Science, Technology & Research Method and system for enabling recovery of data stored in a computer network; a method and a system for recovering data stored in a computer network
WO2005004984A1 (en) 2003-07-14 2005-01-20 Power Paper Ltd. Device and method for the treatment of pilosebaceous disorders
US20050054714A1 (en) 2003-07-17 2005-03-10 Benito Munoz Nitric oxide releasing drugs for Alzheimer's disease
EP1648527A4 (en) 2003-07-25 2008-04-23 Univ Akron STABILIZATION AND IONIC RELEASE OF NITRIC OXIDE RELEASE
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US7314857B2 (en) 2003-08-25 2008-01-01 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
US20070238740A1 (en) 2003-08-28 2007-10-11 Nitromed, Inc. Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
EP1667646A4 (en) 2003-09-26 2007-07-04 David R Whitlock METHOD FOR USE OF AMMONIA-OXIDATING BACTERIA
AU2004275809A1 (en) 2003-09-26 2005-04-07 Nitromed, Inc. Nitrosated glutamic acid compounds, compositions and methods of use
US7485324B2 (en) 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
US20050074506A1 (en) 2003-10-02 2005-04-07 Brainsgate Ltd. Targeted release of nitric oxide in the CNS circulation for modulating the BBB and treating disorders
WO2005037339A1 (en) 2003-10-14 2005-04-28 Cube Medical A/S A balloon for use in angioplasty
US20060286158A1 (en) 2003-10-17 2006-12-21 Calvert Murrell George A Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
US20050171199A1 (en) 2003-10-17 2005-08-04 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
US20060286159A1 (en) 2003-10-17 2006-12-21 Calvert Murrell George A Treatment of persistent active tendinopathy using transdermal glyceryl trinitrate providing durability of effect
US20070059351A1 (en) 2003-10-17 2007-03-15 Murrell George A C Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
US20070053966A1 (en) 2003-10-17 2007-03-08 Robert Ang Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
US20070239107A1 (en) 2003-12-15 2007-10-11 Jon Lundberg Device and Method for Administering Therapeutic Agents
WO2005067986A1 (en) 2004-01-07 2005-07-28 Noxilizer, Inc. Sterilization system and device
US8017074B2 (en) 2004-01-07 2011-09-13 Noxilizer, Inc. Sterilization system and device
US20090131342A1 (en) 2004-01-22 2009-05-21 Nitromed, Inc. Nitrosated and/or nitrosylated compounds, compositions and methods of use
EP1737502B1 (en) 2004-01-22 2014-01-15 The University of Akron Polymer no donor predrug nanofiber coating for medical devices
CN1914169A (zh) 2004-01-27 2007-02-14 默克弗罗斯特公司 作为环氧合酶-2抑制剂的二芳基-2-(5h)-呋喃酮的氧化氮释放前药
US7622502B2 (en) 2004-01-27 2009-11-24 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
US20050165452A1 (en) 2004-01-28 2005-07-28 Medtronic, Inc. Antithrombogenic medical device
US7569559B2 (en) 2004-02-09 2009-08-04 Noxilizer, Inc. Nitric oxide-releasing molecules
JP4738352B2 (ja) 2004-02-09 2011-08-03 アミュレット ファーマシューティカルズ インコーポレイティッド 一酸化窒素放出ポリマー
WO2005077962A2 (en) 2004-02-10 2005-08-25 Purdue Research Foundation Crowned dithiocarbamate metal complexes and methods for their use
EP1732577B1 (en) 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topical delivery of l-arginine to improve body and skin appearance
CA2561141A1 (en) 2004-03-31 2005-11-17 Nitromed, Inc. Methods for treating blood disorders with nitric oxide donor compounds
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US8529548B2 (en) * 2004-04-27 2013-09-10 Smith & Nephew Plc Wound treatment apparatus and method
CA2564399A1 (en) 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
WO2005115440A2 (en) 2004-04-29 2005-12-08 Kahn Nighat N Compositions and method for modulating insulin-activated nitric oxide synthase
US20060240065A1 (en) * 2005-04-26 2006-10-26 Yung-Ming Chen Compositions for medical devices containing agent combinations in controlled volumes
US20050249818A1 (en) 2004-05-03 2005-11-10 Sawan Samuel P Polycationic antimicrobial therapeutic
US8791073B2 (en) 2004-05-14 2014-07-29 William Marsh Rice University Peptide-modified polyurethane compositions and associated methods
US20050265958A1 (en) 2004-05-14 2005-12-01 West Jennifer L Nitric oxide releasing compositions and associated methods
US7582623B2 (en) 2004-05-20 2009-09-01 The Regents Of The University Of California Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
KR20070045187A (ko) 2004-06-10 2007-05-02 고쿠리츠다이가쿠호진 도호쿠다이가쿠 항암제의 효과 증강제
US20060008529A1 (en) 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20060039950A1 (en) 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
AU2005289414B2 (en) 2004-09-27 2010-12-09 Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
US20070154570A1 (en) 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
WO2006041855A2 (en) 2004-10-04 2006-04-20 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
FR2877004B1 (fr) 2004-10-21 2007-03-09 Oreal Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques.
US8388677B2 (en) 2004-10-29 2013-03-05 Boston Scientific Scimed, Inc. Anti-thrombogenic and anti-restenotic vascular medical devices
CA2574535A1 (en) 2004-11-15 2006-05-26 Nitromed, Inc. Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
US20070166255A1 (en) 2004-11-22 2007-07-19 Gupta Shyam K Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
JP5188184B2 (ja) 2004-11-29 2013-04-24 ザ ユニバーシティ オブ アクロン 局所的一酸化窒素供給装置およびその治療的使用方法
WO2006064056A2 (en) 2004-12-16 2006-06-22 Nolabs Ab Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide
EP1681068A1 (en) 2004-12-16 2006-07-19 NOLabs AB Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide
JP2008525321A (ja) 2004-12-24 2008-07-17 ザ ユニバーシティー オブ クイーンズランド 疼痛治療法
JP2008528626A (ja) 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク. ヒドロキシル化されたネビボロールを含む薬学的組成物
EP1690557A1 (en) 2005-02-11 2006-08-16 NOLabs AB Device for treatment of rectal disorders, and manufacturing process for the same
PL1846058T3 (pl) 2005-02-11 2009-12-31 Nolabs Ab Produkt, sposób i zastosowanie go do leczenia neuropatii z wydzielaniem tlenku azotu
EP1690558A1 (en) 2005-02-11 2006-08-16 NOLabs AB Device for treatment of diabetic disorders
WO2006084914A2 (en) 2005-02-11 2006-08-17 Nolabs Ab Device for gastric treatment and manufacturing process for the same
EP1690532A1 (en) 2005-02-11 2006-08-16 NOLabs AB Device for gastric treatment and manufacturing process for the same
WO2006084913A2 (en) 2005-02-11 2006-08-17 Nolabs Ab Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
EP1846009A2 (en) 2005-02-11 2007-10-24 NOLabs AB Improved device for application of medicaments, manufacturing method therefor, and method of treatment
EP1700611A1 (en) 2005-02-11 2006-09-13 NOLabs AB Device for treatment of disorders in the oral cavity, and manufacturing process for the same
EP1757278A1 (en) * 2005-08-23 2007-02-28 NOLabs AB Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer
EP1690554A1 (en) 2005-02-11 2006-08-16 NOLabs AB Device for treatment of infections, including dermatophytosis and onychomycosis
ES2314882T3 (es) 2005-02-11 2009-03-16 Nolabs Ab Dispositivo y metodo para el tratamiento de dermatomicosis y, en particular, de onicomicosis.
EP1858525A2 (en) 2005-02-16 2007-11-28 Nitromed, Inc. Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
AU2006216665A1 (en) 2005-02-24 2006-08-31 Nicox S.A. Nitric oxide enhancing diuretic compounds, compositions and methods of use
US8119840B2 (en) 2005-03-04 2012-02-21 The University Of Akron Ethambutol based nitric oxide donors
WO2006099058A2 (en) 2005-03-09 2006-09-21 Nitromed, Inc. Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use
GB0505035D0 (en) 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
WO2006097348A1 (en) 2005-03-15 2006-09-21 L'oreal Use of agents such as nonpolymeric nitric oxide donors for making the lips full again and/or colouring the lips
EP1704876A1 (en) 2005-03-24 2006-09-27 NOLabs AB Cosmetic treatment, device for performing said treatment and manufacturing method thereof
WO2006100155A1 (en) 2005-03-24 2006-09-28 Nolabs Ab Device for wound care, and manufacturing method thereof, involving the use of nitric oxide
CA2608071A1 (en) 2005-03-24 2006-09-28 Nolabs Ab Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide
EP1871433B1 (en) 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
EP1704877A1 (en) 2005-03-24 2006-09-27 NOLabs AB A wound care device comprising a nitric oxide eluting polymer
EP1704879A1 (en) 2005-03-24 2006-09-27 NOLabs AB Intravascular, interstitial or intraorgan medical device comprising a nitric oxide eluting polymer
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
EP1885375A4 (en) 2005-05-16 2010-12-01 Univ Alberta NOVEL NSAIDS HAVING A DIAZENE-1-IUM-1,2-DIOLATE FRACTION NITRIC OXIDE DONOR
WO2006122573A1 (en) 2005-05-17 2006-11-23 Syntach Ag A device a kit for treatment of disorders in the heart rhythm regulation system
WO2006127591A2 (en) 2005-05-23 2006-11-30 Nitromed, Inc. Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use
WO2006125262A1 (en) 2005-05-24 2006-11-30 Environmental Biotechnology Crc Pty Limited Methods and compositions for regulating biofilm development
EP1888510A4 (en) * 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
EP1731176A1 (en) * 2005-06-01 2006-12-13 NOLabs AB Pre-treatment device comprising nitric oxide
EP1888131A2 (en) 2005-06-01 2008-02-20 NOLabs AB Treatment and pre-treatment device, and manufacturing method therefor, involving nitric oxide
WO2006128743A1 (en) 2005-06-01 2006-12-07 Nolabs Ab Feedstuff
EP1728438A1 (en) 2005-06-01 2006-12-06 NOLabs AB Feedstuff
US8106080B2 (en) 2005-06-09 2012-01-31 Gu-Qi Wang Compositions and methods for enhancing nitric oxide delivery
EP1896091B1 (en) 2005-06-30 2011-06-22 Accord Biomaterials, Inc. Nitric oxide coatings for medical devices
US20080241208A1 (en) 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
US20080139450A1 (en) 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
AU2006265707B2 (en) 2005-07-01 2012-06-14 Kane Biotech Inc. Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
US20080152596A1 (en) 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
BRPI0503201B8 (pt) 2005-07-28 2021-05-25 Sci Tech Produtos Medicos Ltda stents revestidos com blendas poliméricas hidrofílicas, eluidoras de óxido nítrico e s-nitrosotióis
EP1915157A4 (en) 2005-08-02 2010-09-01 Nicox Sa NICKEL OXYGENIZING ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND USE PROCESSES
US8021679B2 (en) 2005-08-25 2011-09-20 Medtronic Vascular, Inc Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
US20070053955A1 (en) 2005-08-26 2007-03-08 Nestec S.A. Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
US20070048344A1 (en) 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
US20070053952A1 (en) 2005-09-07 2007-03-08 Medtronic Vascular, Inc. Nitric oxide-releasing polymers derived from modified polymers
EP1764119A1 (en) 2005-09-09 2007-03-21 NOLabs AB Implants with improved osteointegration
US20090010989A1 (en) 2005-09-12 2009-01-08 N0Labs Ab Coating For Implants and Implants With Improved Osteointegration, and Manufacturing Method
CN101282735A (zh) 2005-10-11 2008-10-08 拜耳消费者保健股份公司 掩蔽金属味道的铁盐和铜盐混合物
US20070088345A1 (en) 2005-10-13 2007-04-19 Ust Inc. Applications of HIFU and chemotherapy
US7531164B2 (en) 2005-10-21 2009-05-12 Duke University Preventing bacterial or viral infectivity and composition containing infection preventing additive
AU2006309212B2 (en) 2005-10-31 2011-09-15 Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
WO2007053578A2 (en) 2005-10-31 2007-05-10 Amulet Pharmaceuticals, Inc. Multi-phasic nitric oxide and drug co-eluting stent coatings
EP1790335A1 (en) 2005-11-14 2007-05-30 NOLabs AB Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract
US7838023B2 (en) 2005-11-16 2010-11-23 Nitromed, Inc. Furoxan compounds, compositions and methods of use
US20070116785A1 (en) 2005-11-18 2007-05-24 Miller Christopher C Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
JP2009518069A (ja) 2005-12-02 2009-05-07 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン 組成物、コーティング及びデバイス、並びにそれらの製造方法及び使用方法
US20070129690A1 (en) 2005-12-02 2007-06-07 Joel Rosenblatt Catheter with polymeric coating
EP1968615A4 (en) 2005-12-06 2010-08-04 Amulet Pharmaceuticals Inc POLYMERS RELEASING NITRIC OXIDE
US20070243262A1 (en) 2005-12-21 2007-10-18 Hurley Kevin P Stable S-nitrosothiol formulations
WO2007084533A2 (en) 2006-01-17 2007-07-26 The University Of Akron Debridement method using topical nitric oxide donor devices and compositions
EP1979487A4 (en) 2006-01-26 2010-05-05 Bebaas Inc COBALAMINE COMPOSITIONS FOR THE TREATMENT OF CANCER
US20070202155A1 (en) 2006-02-03 2007-08-30 Cure Therapeutics, Inc. Low dose no donor-containing transdermal patch
EP1983975B1 (en) 2006-02-03 2015-07-29 Giulio Cossu Method of treatment for muscular dystrophy
NZ569396A (en) 2006-02-03 2011-06-30 Nicox Sa Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
US20070203242A1 (en) 2006-02-27 2007-08-30 Calwood Nutritionals, Inc. Method for treating gastric reflux
US20070219208A1 (en) 2006-02-27 2007-09-20 Balaraman Kalyanaraman Methods for Treating Cancer
US7645749B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol nitroderivatives and use thereof
US7645748B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol phosphorylnitroderivatives and use thereof
WO2007127725A2 (en) 2006-04-24 2007-11-08 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods
US8241619B2 (en) 2006-05-15 2012-08-14 Medtronic Vascular, Inc. Hindered amine nitric oxide donating polymers for coating medical devices
US20080171351A1 (en) 2006-05-22 2008-07-17 University Of Notre Dame Du Lac Probes for anionic cell surface detection
EP2029106A2 (en) 2006-06-07 2009-03-04 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
WO2007149437A1 (en) 2006-06-16 2007-12-27 Alltech, Inc. Reduction of antibiotic resistance in bacteria
US8333997B2 (en) 2006-06-21 2012-12-18 Albert Einstein College Of Medicine Of Yeshiva University Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
WO2008038147A2 (en) 2006-07-05 2008-04-03 Foamix Ltd. Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof
WO2008012845A1 (en) 2006-07-26 2008-01-31 Stmicroelectronics S.R.L. Use of nitroaniline derivatives for the production of nitric oxide
US20080025972A1 (en) 2006-07-26 2008-01-31 Duke University Treating sex steriod responsive disorders
EP2054089B1 (en) * 2006-08-03 2018-12-26 The Board of Trustees of the Leland Stanford Junior University Devices and bandages for the treatment or prevention of scars and/or keloids and methods and kits therefor
GB0616350D0 (en) 2006-08-17 2006-09-27 Univ St Andrews Adsorption and release of nitric oxide in metal organic frameworks
MX2009002205A (es) * 2006-08-30 2009-07-02 Southeastern Medical Technolog Metodos, composiciones y aparatos para tratar heridas con presiones alteradas respecto a la presion atmosferica.
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
US20080166303A1 (en) 2006-09-08 2008-07-10 Dov Tamarkin Colored or colorable foamable composition and foam
GB0618711D0 (en) 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2009007785A2 (en) 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
RU2467759C2 (ru) 2006-11-15 2012-11-27 Артрайтис Рилиф Плас Лтд Состав для местного использования и его применения
GB0623531D0 (en) 2006-11-25 2007-01-03 Univ St Andrews Nitric oxide storage and production
EP2097065A2 (en) 2006-11-29 2009-09-09 Foamix Ltd. Foamable waterless compositions with modulating agents
US8221690B2 (en) 2007-10-30 2012-07-17 The Invention Science Fund I, Llc Systems and devices that utilize photolyzable nitric oxide donors
US8642093B2 (en) 2007-10-30 2014-02-04 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US7975699B2 (en) 2007-10-30 2011-07-12 The Invention Science Fund I, Llc Condoms configured to facilitate release of nitric oxide
US7862598B2 (en) 2007-10-30 2011-01-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US20090110933A1 (en) 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and devices related to nitric oxide releasing materials
US20080292560A1 (en) 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US20080175881A1 (en) 2007-01-18 2008-07-24 Boston Scientific Scimed, Inc. Blood-contacting medical devices for the release of nitric oxide and anti-restenotic agents
EP2114427B1 (en) 2007-01-30 2014-06-25 New York University Peptides for treatment of conditions associated with nitric oxide
US20100099729A1 (en) 2007-02-05 2010-04-22 Nicox S.A. Nitric oxide donor compounds
US20080193385A1 (en) 2007-02-08 2008-08-14 Todd Maibach Compositions and methods for treating neuropathy
US20080193566A1 (en) 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
US20100087370A1 (en) 2007-02-14 2010-04-08 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
US7811600B2 (en) 2007-03-08 2010-10-12 Medtronic Vascular, Inc. Nitric oxide donating medical devices and methods of making same
US20100178319A1 (en) 2007-03-27 2010-07-15 Lars Lindgren Topical Dermal Delivery Device For Nitric Oxide Delivery
US8598368B2 (en) 2007-04-20 2013-12-03 Duke University Stable neutral nitric oxide source
WO2008150505A1 (en) 2007-06-01 2008-12-11 Amulet Pharmaceuticals, Inc. Compounds, polymers and methods for treating gastrointestinal dysfunction
WO2008157393A1 (en) 2007-06-15 2008-12-24 Ikaria, Inc. Compositions comprising sulfide alone or in combination with nitric oxide and their use to
US8273828B2 (en) 2007-07-24 2012-09-25 Medtronic Vascular, Inc. Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation
AU2008279755B2 (en) 2007-07-26 2014-01-09 Duke University Measuring amount of bound and combined nitric oxide in blood
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
GB0715554D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
GB0715556D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
CA2599082A1 (en) 2007-08-27 2009-02-27 Ping I. Lee Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
US20090088411A1 (en) 2007-08-31 2009-04-02 Topigen Pharmaceuticals Inc. No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties
WO2009056991A2 (en) 2007-09-04 2009-05-07 Foamix Ltd. Device for delivery of a foamable composition
CA2700172A1 (en) 2007-09-21 2009-03-26 Enox Biopharma, Inc. Antimicrobial gas-releasing ear drainage tubes
US9453115B2 (en) 2007-10-12 2016-09-27 Honeywell International Inc. Stabilization of polyurethane foam polyol premixes containing halogenated olefin blowing agents
US8399005B2 (en) * 2007-10-12 2013-03-19 University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
US20090112055A1 (en) 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Sleeves configured to facilitate release of nitric oxide
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US8349262B2 (en) 2007-10-30 2013-01-08 The Invention Science Fund I, Llc Nitric oxide permeable housings
US20090112193A1 (en) 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and devices that utilize photolyzable nitric oxide donors
US7897399B2 (en) 2007-10-30 2011-03-01 The Invention Science Fund I, Llc Nitric oxide sensors and systems
WO2009064861A2 (en) 2007-11-13 2009-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nitric oxide-releasing diazeniumdiolated polymers, compositions, medical devices, and uses thereof
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009073643A2 (en) 2007-12-03 2009-06-11 Cleveland State University Nitric oxide release coatings incorporating nitric oxide synthase enzyme
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
BRPI0705396B1 (pt) 2007-12-12 2021-10-05 Universidade Estadual De Campinas - Unicamp Compostos derivados ftalimídicos
IE20070934A1 (en) 2007-12-21 2009-06-24 Trinity College Dublin Efficient aspirin prodrugs
EP2237788A4 (en) 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US20090177133A1 (en) * 2008-01-04 2009-07-09 Kristine Kieswetter Reduced pressure dressing coated with biomolecules
EP2224930B1 (en) 2008-01-04 2016-06-15 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
CA2711703A1 (en) 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
JP5623916B2 (ja) 2008-01-31 2014-11-12 バンダービルト・ユニバーシティVanderbilt University 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物
US8720436B2 (en) 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US8003811B2 (en) 2008-02-07 2011-08-23 Nicox S.A. Nitric oxide donor compounds
US20090222088A1 (en) 2008-02-29 2009-09-03 Medtronic Vascular, Inc. Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
US20090232868A1 (en) 2008-03-17 2009-09-17 Medtronic Vascular, Inc. Nitric Oxide Releasing Polymer Composition
US20090232863A1 (en) 2008-03-17 2009-09-17 Medtronic Vascular, Inc. Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
WO2009124379A1 (en) 2008-04-09 2009-10-15 Enox Biopharma, Inc. Biofilm-inhibiting catheters and tubings
CN102065848A (zh) 2008-04-21 2011-05-18 3M创新有限公司 释放一氧化一氮的组合物、装置和方法
US20120141384A1 (en) 2008-05-06 2012-06-07 Dov Tamarkin Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
US20110104240A1 (en) 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections
US8852640B2 (en) 2008-07-03 2014-10-07 Ecole Polytechnique Federale De Lausanne (Epfl) Micelles for delivery of nitric oxide
US20100040703A1 (en) 2008-08-13 2010-02-18 Chris Miller Use of nitric oxide
EP2331606B1 (en) 2008-09-19 2016-11-02 Northwestern University Biodegradable nitric oxide generating polymers and related biomedical devices
US7807716B2 (en) 2008-09-24 2010-10-05 Oral Delivery Technology Ltd. Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
US20100086530A1 (en) 2008-10-06 2010-04-08 Martinov Norman P Cancer-tumor necrosis by artery nutrient-oxygen blocking
WO2010045465A1 (en) 2008-10-15 2010-04-22 The University Of Tennessee Research Foundation Method and device for detection of bioavailable drug concentration in a fluid sample
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
US20100099766A1 (en) 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
CA2740135A1 (en) 2008-10-30 2010-05-06 Chris Miller Wound dressings comprising a nitric oxide gas producing component and an oxygen releasing component
US20100166603A1 (en) 2008-10-31 2010-07-01 Noxilizer, Inc. Powder Sterilization
US8158187B2 (en) 2008-12-19 2012-04-17 Medtronic Vascular, Inc. Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices
US20100197702A1 (en) 2009-02-04 2010-08-05 Hellberg Mark R Ophthalmic composition with nitric oxide donor compound and method of forming and using same
WO2010096320A2 (en) 2009-02-18 2010-08-26 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US8062653B2 (en) 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US9278113B2 (en) 2009-03-30 2016-03-08 The Board Of Regents, The University Of Texas System Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof
US8236341B2 (en) 2009-04-02 2012-08-07 Medtronic Vascular, Inc. Poly(tetrafluoroethylene) polymer with nitric oxide donating surface
EP2413838A4 (en) * 2009-04-03 2012-09-19 Biomerix Corp AT LEAST PARTIALLY RESORBIBLE RETICULATED ELASTOMER MATRIX PARTICLES AND PRODUCTION METHOD
US8709465B2 (en) 2009-04-13 2014-04-29 Medtronic Vascular, Inc. Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
EP2445508B1 (en) 2009-06-22 2018-11-14 VERO Biotech LLC Nitric oxide therapies
US20110059189A1 (en) 2009-09-08 2011-03-10 Cisne Enterprises Inc. Method and composition for treating cancer, effecting apoptosis and treating retroviral infections
WO2011047013A1 (en) 2009-10-13 2011-04-21 Novan, Inc. Nitric oxide-releasing coatings

Also Published As

Publication number Publication date
EP2467173B1 (en) 2019-04-24
US20180214598A1 (en) 2018-08-02
BR112012003804A2 (pt) 2015-09-01
CA2771389C (en) 2019-04-09
EP2467173A2 (en) 2012-06-27
US20120136323A1 (en) 2012-05-31
CN102695528A (zh) 2012-09-26
CN102695528B (zh) 2016-07-13
CA2771389A1 (en) 2011-02-24
BR112012003804B1 (pt) 2019-02-19
US11583608B2 (en) 2023-02-21
EP2467173B8 (en) 2019-06-19
WO2011022680A2 (en) 2011-02-24
US9919072B2 (en) 2018-03-20
WO2011022680A3 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
DK2467173T3 (da) Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK3614595T3 (da) Fremgangsmåde og indretning til forbedrede statusrapporter
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK2429109T3 (da) Kommunikationsapparat, kommunikationsfremgangsmåde, computerprogram og kommunikationssystem
DK2320911T3 (da) Vasokonstriktionspræparater og fremgangsmåder til anvendelse deraf
DE102009036860A8 (de) Bedieneinheit, Gerät und Verfahren
DK2358669T3 (da) Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf
DK3599279T3 (da) Sammensætninger og fremgangsmåder, som omfatter proteasevarianter
DK2388351T3 (da) Stål til overfladehærdning for maskinstruktur-anvendelse, og komponent til maskinstruktur-anvendelse
BRPI1007767A2 (pt) dispositivo de colocação, e, aparelho de afixação reversível
BR112012011910A2 (pt) dispositivo e método
DK3263100T3 (da) L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf
DK2337568T3 (da) Fremgangsmåder og midler til blødvævsteknologi
BRPI1012883A2 (pt) dispositivo intercorporal.
DK2337837T3 (da) Alpha-amylase-blandinger og fremgangsmåder til anvendelse heraf
DK2482871T3 (da) Anti-bolus-kontrol metode og tilsvarende enhed
BRPI0918958A2 (pt) dispositivo móvel, e, método
BRPI0913752A2 (pt) método, dispositivo, e, estrutura
BR112013013584A2 (pt) endoscópio, e, método
DK2265793T3 (da) Undervandstestapparat, konstruktionsenhed og fremgangsmåde
DK2309938T3 (da) Kryokirurgiske systemer og fremgangsmåder til anvendelse heraf
DK2584921T3 (da) Sondeernæringspakninger og fremgangsmåder til anvendelse deraf
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2408807T3 (da) Fremgangsmåde til terapeutisk anvendelse